Skip to content

Industry News

Darby Private Equity Invests in Pharma Consulting Group

12 February 2019

Darby Private Equity, through Darby Latin American Private Debt Fund III, L.P, has invested in Pharma Consulting Group, a Latin American specialty pharmaceutical distribution company. Transaction details were not disclosed.

(Press Release) Darby Private Equity (“Darby”), a private equity arm of Franklin Templeton, today announced that Darby Latin American Private Debt Fund III, L.P. (“DLAPDF III”) completed an investment in Pharma Consulting Group, S.A. (known as “Biopas”), a specialty pharmaceutical distribution company focused on in-licensing, selling and marketing innovative prescription pharmaceutical products, cosmetics and medical devices. Transaction details were not disclosed.

Since Biopas was founded in 2002, it has expanded into 13 Latin American countries. The company’s primary market is Colombia, and it also has a strong presence in Peru, Ecuador, Chile and Argentina. Biopas is headquartered in Panama and operates in five main business units: Immunology, Rare Diseases, Central Nervous Systems and Oncology, Specialty Care, and Dermatology.

Pascal Forget, Biopas Co-founder and CEO, highlighted that “Darby’s investment will allow us to solidify Biopas as a key regional player in the healthcare industry, maintaining a clear leadership position in the countries where we operate and expanding into other key markets in the region. The investment we received will help the company achieve sustainable growth, while continuing to provide the full range of products currently in our portfolio, as well as introduce new lifechanging medicines to Latin America.”

“We are excited to partner with Biopas, a leading pharmaceutical company that is focused on transforming the lives of patients in Latin America. This transaction aligns with Darby’s commitment to investing in Latin American companies with strong management and a successful track record,” commented Ignacio Aicardi, Managing Director at Darby.

The investment in Biopas adds to Darby’s long history of successful investments in Latin America. Darby has played a pioneering role in bringing private equity and private debt investments to emerging market regions.